У каждого типа кожи — свои потребности. Выберите проблему и получите рекомендации подходящих дерматокосметических средств.
This is what
we stand for
We believe no one should suffer
because of their skin issues
That’s why we partner with dermatologists to understand and answer all skin needs on all continents. We continuously work together with dermatologists, pediatricians and oncologists to develop the most efficient formulas for their patients’ needs, run clinical trials pre-launch and monitor their efficacy overtime.
For new project and scientific innovations, we consult with our La Roche-Posay expert medical boards made up of doctors from a range of specialties. They work closely with us to co-create products that are very well tolerated, even on skin weakened by medical conditions or procedures.
Your skin deserves the
most tolerated, most
and most useful
research to bring you useful and efficient innovations, such as Lipikar
AP+M for atopic eczema prone skin. We believe that microbiome
science is the future of skin health and have made 13 publications
and run19 clinical studies on 1200 people since 2011.
For 25 years,
Anthelios has been
technological services, such as Spotscan, to bring expert advice to the
greatest number of people. EFFACLAR SPOTSCAN is a life-changing
innovation that uses artificial intelligence based on extensive scientific
data to make personalized acne diagnosis.
We strive for
combined with maximum
safety and tolerance
tolerance thanks to ingredient selection criteria, stringent testing
protocols on specific skin concerns and ongoing expert partnerships.
quality of life
Because 89% of children
with eczema experience
disrupted sleep during
new formula to rebalance the microbiome, soothe and space out
dryness flare-ups. The result: 75% improvement in quality of
sleep for people with eczema-prone skin.
limiting skin side effects
and improving cancer
patients’ everyday comfort
Because 40% of adult
women suffer from acne
women with acne-prone skin say they feel ashamed, ugly, and
prisoners of their own skin. This is why we launched Effaclar Serum,
the first ultra-concentrated daily peeling for adult acne-prone skin. It
brings anti-imperfections, anti-marks, visible efficacy from the first
morning and 49% less acne marks in 28 days.
80%* of people with
cancer suffer from
skin side effects of
make sure everyone is
solutions exist for
La Roche-Posay products patients’ everyday skin comfort.